226 related articles for article (PubMed ID: 20842791)
1. Dutasteride and prostate cancer.
Klotz L
N Engl J Med; 2010 Aug; 363(8):794; author reply 795-6. PubMed ID: 20842791
[No Abstract] [Full Text] [Related]
2. Dutasteride and prostate cancer.
Schröder FH; Roobol MJ
N Engl J Med; 2010 Aug; 363(8):793-4; author reply 794-5. PubMed ID: 20842789
[No Abstract] [Full Text] [Related]
3. Dutasteride and prostate cancer.
Garattini S; Bertele' V
N Engl J Med; 2010 Aug; 363(8):794; author reply 794-6. PubMed ID: 20842790
[No Abstract] [Full Text] [Related]
4. Dutasteride and prostate cancer.
Kiemeney LA; Bosland MC
N Engl J Med; 2010 Aug; 363(8):793; author reply 794-5. PubMed ID: 20718671
[No Abstract] [Full Text] [Related]
5. Effect of dutasteride on the risk of prostate cancer.
Andriole GL; Bostwick DG; Brawley OW; Gomella LG; Marberger M; Montorsi F; Pettaway CA; Tammela TL; Teloken C; Tindall DJ; Somerville MC; Wilson TH; Fowler IL; Rittmaster RS;
N Engl J Med; 2010 Apr; 362(13):1192-202. PubMed ID: 20357281
[TBL] [Abstract][Full Text] [Related]
6. [Dutasteride provides chemoprevention].
Werner F
Aktuelle Urol; 2006 Sep; 37(5 Suppl):18. PubMed ID: 23646395
[No Abstract] [Full Text] [Related]
7. [Dual 5-alpha reductase inhibitors in BPH (benign prostatic hyperplasia). Already after 1 month prostate shrinks].
MMW Fortschr Med; 2003 Feb; 145(9):54. PubMed ID: 12666533
[No Abstract] [Full Text] [Related]
8. Chemoprevention of prostate cancer.
Walsh PC
N Engl J Med; 2010 Apr; 362(13):1237-8. PubMed ID: 20357287
[No Abstract] [Full Text] [Related]
9. Ask the doctor. I take Avodart for my enlarged prostate. But I heard that Avodart increases prostate cancer risk. Is that true? Should I quit taking Avodart?
Garnick MB
Harv Health Lett; 2012 Jan; 37(3):8. PubMed ID: 22400165
[No Abstract] [Full Text] [Related]
10. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
Andriole GL; Roehrborn C; Schulman C; Slawin KM; Somerville M; Rittmaster RS
Urology; 2004 Sep; 64(3):537-41; discussion 542-3. PubMed ID: 15351586
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia.
Roehrborn CG; Marks LS; Fenter T; Freedman S; Tuttle J; Gittleman M; Morrill B; Wolford ET
Urology; 2004 Apr; 63(4):709-15. PubMed ID: 15072886
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.
Andriole G; Bostwick D; Brawley O; Gomella L; Marberger M; Tindall D; Breed S; Somerville M; Rittmaster R;
J Urol; 2004 Oct; 172(4 Pt 1):1314-7. PubMed ID: 15371831
[TBL] [Abstract][Full Text] [Related]
13. Cost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigen.
Svatek RS; Lotan Y
Cancer Prev Res (Phila); 2011 Feb; 4(2):277-83. PubMed ID: 21163937
[TBL] [Abstract][Full Text] [Related]
14. Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia.
Djavan B; Milani S; Fong YK
Expert Opin Pharmacother; 2005 Feb; 6(2):311-7. PubMed ID: 15757426
[TBL] [Abstract][Full Text] [Related]
15. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
Kaplan SA
J Urol; 2005 Nov; 174(5):1904-5. PubMed ID: 16217336
[No Abstract] [Full Text] [Related]
16. Editorial comment.
Madersbacher S
Urology; 2011 Sep; 78(3):646-7. PubMed ID: 21884913
[No Abstract] [Full Text] [Related]
17. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
[TBL] [Abstract][Full Text] [Related]
18. [Considerations about the value of prostate specific antigen in patients treated with 5-α reductase].
Brenes Bermúdez FJ
Semergen; 2013 Mar; 39(2):118. PubMed ID: 23452542
[No Abstract] [Full Text] [Related]
19. Preventing prostate cancer: new analyses put finasteride back on the map.
Vastag B
J Natl Cancer Inst; 2008 Aug; 100(16):1132-3. PubMed ID: 18695128
[No Abstract] [Full Text] [Related]
20. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
